The impact of BNO 1030 on phagocytic activity of white blood cells in rats with type 1 diabetes mellitus
Journal Title: Актуальна інфектологія - Year 2017, Vol 13, Issue 5
Abstract
Background. In the pathogenesis of type 1 diabetes mellitus (DM1) and many of its complications, an important place belongs to a violation of the functional capacity of the immune system, which is the subject of numerous studies. Considering the effectiveness of immunomodulating therapy for DM1 and its complications, one of the most important problems is the search for new effective and harmless immunocorrecting agents with high pharmacological activity. The purpose of this study was to evaluate the effect of the phytopreparation BNO 1030 on the phagocytic activity of blood leukocytes in rats with DM1. Materials and methods. Experimental DM1 in rats was induced by a single intraperitoneal injection of streptozotocin. The percentage of phagocytic cells and macrophage uptake of live fluorescent bacteria in the samples were determined using fluorescent live bacteria Escherichia coli. Results. The effect of the drug BNO 1030 on the phagocytic activity of white blood cells with DM1 in rats was investigated. Under hyperglycemia it was found changes in the redistribution of the main types of leukocytes, namely granulocytes and agranulocytes. The administration of the drug BNO 1030 to both control and diabetic animals resulted in an increase in the number of agranulocytes, which may indicate a modulating effect of the drug on the immune system of animals. Under these conditions, phagocytic activity of leukocytes was decreased as phagocytic number in group of diabetic rats was reduced by 42 % in comparison with group of control animals. BNO 1030 administration to diabetic rats caused an increase of phagocyte number by 24 % compared to the group of diabetic animals. These changes, in turn, are also accompanied by a decrease of phagocytic index as in diabetes, and when drug was administered to experimental groups, indicating disorders in nonspecific cellular immune system. Conclusions. BNO 1030 due to its immunomodulatory effect is effective in the treatment of DM1 and its comorbidity with other chronic diseases.
Authors and Affiliations
Yu. V. Gavrylenko
Oropharyngeal microbiota in children during measles rash
Background. The purpose of our work was to study the oropharyngeal microbiota in children with measles. Materials and methods. We observed 35 children who got sick with a typical form of measles and were hospitalized. Am...
Pathogenetic Mechanisms of Brain Damage at Neuroinfections in Children
The article presents the value of neuron-specific enolase and autoantibodies to glutamate receptor NR2A subunits as markers of ischemia and neurodestruction at acute meningitis in children. Presence of autoantibodies to...
About the Ways to Improve the Quality and Efficiency of Antiepidemic Measures on Localization of the Epidemic Focus of Infections Causing Emergencies in the Field of Sanitary and Epidemiological Wellbeing of the Population
Since the identification of the virus in the Democratic Republic of the Congo in 1976, the total number of persons suffered from the Ebola outbreak, is 24,282 people by February 2015, including 9,976 recorded lethal case...
The Etiology and Pathogenesis of Hepatitis and Liver Cirrhosis under the Influence of Dysentery Toxin
Chronic intoxication of white rats by intravenous administration of dysentery toxin causes in animals within 2–4 months the development of liver cirrhosis. A particularly intensive development of cirrhosis is observed in...
Aspects of treatment of lower respiratory tract infections in terms of clinical guidelines of different countries (bronchiolitis, bronchitis, community-acquired pneumonia)
According to the international protocols, the treatment of lower respiratory tract infections has its own characteristics in different countries. In general, only oxygen therapy and proper hydration have sufficient evide...